.jpg?itok=mqcCRg-W "Protagonist Therapeutics founder Associate Professor Mark Smythe")
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016
The Australian Academy of Technological Sciences and Engineering has named a University of Queensland Executive Dean, and a prominent alumnus and adjunct Associate Professor, as Fellows.
28 October 2016
Projects spanning social welfare, diabetes, climate change and schizophrenia featured at the University of Queensland’s $592,187 Research Week awards last night.
14 September 2016
